SCHEMBL8477764

SCHEMBL8477764

O=C(O)CN1CCNCCN(CC(=O)O)C(CC(O)COc2ccc(C(=O)O)cc2)CN(CC(=O)O)CC1

nearest known ligand 0.42

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.41
KDM1A O60341 1/20 0.39
EGFR P00533 1/20 0.39
MAPK1 P28482 2/20 0.39
ALDH1A1 P00352 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PLA2G4B P0C869 1/20 0.38
ABCB1 P08183 5/20 0.38
HTR7 P34969 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8478646 0.92 MAPT (0.39) MAPTEGFRMAPK1ALDH1A1CYP2D6
SCHEMBL8482399 0.91 KDM4E (0.41) MAPTMAPK1ALDH1A1CYP2D6
SCHEMBL8478346 0.91 KDM1A (0.41) MAPTKDM1AEGFRMAPK1ALDH1A1
SCHEMBL8478317 0.89 ITGB3 (0.41) MAPTEGFRALDH1A1CYP2D6CYP2C9
SCHEMBL8482595 0.86 S1PR1 (0.37) MAPTEGFRALDH1A1CYP2D6CYP2C9
SCHEMBL14001890 0.84 MAPT (0.59) MAPTMAPK1ALDH1A1CYP2D6CYP2C9
SCHEMBL8479012 0.81 ESRRG (0.39) MAPTEGFRALDH1A1SMN1; SMN2
SCHEMBL8505444 0.80 CHRM5 (0.30)
SCHEMBL8478663 0.79 EGFR (0.49) MAPTEGFRALDH1A1SMN1; SMN2
SCHEMBL7882866 0.77 MAPT (0.67) MAPTKDM1AMAPK1ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5871709-A TETRAAZACYCLODODECANE COMPOUNDS SUBSTITUTED WITH ALKYL CARBOXY COMPOUNDS FOR CARDIOVASCULAR DISORDERS AND BRAIN TUMORS SCHERING AKTIENGESELLSCHAFT (DE) 1999-02-16 US disclosed